Luisa Lina Villa
Luisa Lina Villa
Professora de Oncologia Básica, Depto Radiologia da Faculdade de Medicina da Universidade de São
Verified email at hc.fm.usp.br
Title
Cited by
Cited by
Year
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Future II Study Group
New England Journal of Medicine 356 (19), 1915-1927, 2007
21972007
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre …
LL Villa, RLR Costa, CA Petta, RP Andrade, KA Ault, AR Giuliano, ...
The lancet oncology 6 (5), 271-278, 2005
21782005
Updating the natural history of HPV and anogenital cancer
AB Moscicki, M Schiffman, S Kjaer, LL Villa
Vaccine 24, S42-S51, 2006
1186*2006
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
EL Franco, LL Villa, JP Sobrinho, JM Prado, MC Rousseau, M Désy, ...
The Journal of infectious diseases 180 (5), 1415-1423, 1999
8891999
HPV type-distribution in women with and without cervical neoplastic diseases
G Clifford, S Franceschi, M Diaz, N Muñoz, LL Villa
Vaccine 24, S26-S34, 2006
8022006
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia
NF Schlecht, S Kulaga, J Robitaille, S Ferreira, M Santos, RA Miyamura, ...
Jama 286 (24), 3106-3114, 2001
7882001
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a …
KA Ault, Future II Study Group
The Lancet 369 (9576), 1861-1868, 2007
7852007
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
LL Villa, RLR Costa, CA Petta, RP Andrade, J Paavonen, OE Iversen, ...
British journal of cancer 95 (11), 1459-1466, 2006
6842006
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in …
DR Brown, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ...
The Journal of infectious diseases 199 (7), 926-935, 2009
6342009
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
LL Villa, KA Ault, AR Giuliano, RLR Costa, CA Petta, RP Andrade, ...
Vaccine 24 (27-28), 5571-5583, 2006
6182006
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide …
HU Bernard, SY Chan, MM Manos, CK Ong, LL Villa, H Delius, CL Peyton, ...
Journal of Infectious Diseases 170 (5), 1077-1085, 1994
6131994
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study
AR Giuliano, JH Lee, W Fulp, LL Villa, E Lazcano, MR Papenfuss, ...
The Lancet 377 (9769), 932-940, 2011
4982011
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts …
Future I/II Study Group
The BMJ 341, 2010
4832010
Numerical simulation of two-dimensional flows over a circular cylinder using the immersed boundary method
ALFLE Silva, A Silveira-Neto, JJR Damasceno
Journal of Computational Physics 189 (2), 351-370, 2003
4702003
Planning cancer control in Latin America and the Caribbean
PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ...
The Lancet Oncology 14 (5), 391-436, 2013
4612013
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
N Muñoz, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ...
Journal of the National Cancer Institute 102 (5), 325-339, 2010
4282010
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia
NF Schlecht, RW Platt, E Duarte-Franco, MC Costa, JP Sobrinho, ...
Journal of the National Cancer Institute 95 (17), 1336-1343, 2003
4032003
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
JT Schiller, X Castellsagué, LL Villa, A Hildesheim
Vaccine 26, K53-K61, 2008
3912008
The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States
AR Giuliano, E Lazcano-Ponce, LL Villa, R Flores, J Salmeron, JH Lee, ...
Cancer Epidemiology and Prevention Biomarkers 17 (8), 2036-2043, 2008
3752008
Human papillomavirus infections with multiple types and risk of cervical neoplasia
H Trottier, S Mahmud, MC Costa, JP Sobrinho, E Duarte-Franco, ...
Cancer Epidemiology and Prevention Biomarkers 15 (7), 1274-1280, 2006
3692006
The system can't perform the operation now. Try again later.
Articles 1–20